Company intelligence / Profile preview

Vasc-Alert

West Lafayette, Indiana, United States

Ownership: Private
Development stage: Other

Overview

A validation study published in The Journal of Vascular Access demonstrated that patients with high-risk Vasc-Alert Access Risk Scores were seven times more likely to experience stenosis than those with low-risk scores. Investigators estimated the technology can decrease thrombosis incidence by 30-40%.

Therapeutic areas: CardiovascularNephrology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Henry Ford Health Systems (original developer)

Beyond the preview

Go deeper on Vasc-Alert.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vasc-Alert.

Explore the full profile